PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jvirolPermissionsJournals.ASM.orgJournalJV ArticleJournal InfoAuthorsReviewers
 
J Virol. 1996 April; 70(4): 2503–2507.
PMCID: PMC190095

Plasma viral RNA load predicts disease progression in accelerated feline immunodeficiency virus infection.

Abstract

Viral RNA load has been shown to indicate disease stage and predict the rapidity of disease progression in human immunodeficiency virus type 1 (HIV-1)-infected individuals. We had previously demonstrated that feline immunodeficiency virus (FIV) RNA levels in plasma correlate with disease stage in infected cats. Here we expand upon those observations by demonstrating that plasma virus load is 1 to 2 logs higher in cats with rapidly progressive FIV disease than in long-term survivors. Differences in plasma FIV RNA levels are evident by 1 to 2 weeks after infection and are consistent throughout infection. We also evaluated humoral immune responses in FIV-infected cats for correlation with survival times. Total anti-FIV antibody titers did not differ between cats with rapidly progressive FIV disease and long-term survivors. These findings indicate that virus replication plays an important role in FIV disease progression, as it does in HIV-1 disease progression. The parallels in virus loads and disease progressions between HIV-1 and FIV support the idea that the accelerated disease model is well suited for the study of therapeutic agents directed at reducing lentiviral replication.

Full Text

The Full Text of this article is available as a PDF (186K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ackley CD, Yamamoto JK, Levy N, Pedersen NC, Cooper MD. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol. 1990 Nov;64(11):5652–5655. [PMC free article] [PubMed]
  • Baumberger C, Kinloch-de-Loës S, Yerly S, Hirschel B, Perrin L. High levels of circulating RNA in patients with symptomatic HIV-1 infection. AIDS. 1993 Nov;7 (Suppl 2):S59–S64. [PubMed]
  • Bendinelli M, Pistello M, Lombardi S, Poli A, Garzelli C, Matteucci D, Ceccherini-Nelli L, Malvaldi G, Tozzini F. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev. 1995 Jan;8(1):87–112. [PMC free article] [PubMed]
  • Cloyd MW, Lynn WS. Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology. Virology. 1991 Apr;181(2):500–511. [PubMed]
  • Cloyd MW, Moore BE. Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates. Virology. 1990 Jan;174(1):103–116. [PubMed]
  • Cooper DA, Gold J, Maclean P, Donovan B, Finlayson R, Barnes TG, Michelmore HM, Brooke P, Penny R. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet. 1985 Mar 9;1(8428):537–540. [PubMed]
  • Diehl LJ, Mathiason-DuBard CK, O'Neil LL, Hoover EA. Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR. J Virol. 1995 Apr;69(4):2328–2332. [PMC free article] [PubMed]
  • English RV, Nelson P, Johnson CM, Nasisse M, Tompkins WA, Tompkins MB. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis. 1994 Sep;170(3):543–552. [PubMed]
  • George JW, Pedersen NC, Higgins J. The effect of age on the course of experimental feline immunodeficiency virus infection in cats. AIDS Res Hum Retroviruses. 1993 Sep;9(9):897–905. [PubMed]
  • Graziosi C, Pantaleo G, Butini L, Demarest JF, Saag MS, Shaw GM, Fauci AS. Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6405–6409. [PubMed]
  • Graziosi C, Pantaleo G, Demarest JF, Cohen OJ, Vaccarezza M, Butini L, Montroni M, Fauci AS. HIV-1 infection in the lymphoid organs. AIDS. 1993 Nov;7 (Suppl 2):S53–S58. [PubMed]
  • Gupta P, Kingsley L, Armstrong J, Ding M, Cottrill M, Rinaldo C. Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology. 1993 Oct;196(2):586–595. [PubMed]
  • Hirsch VM, Dapolito G, Johnson PR, Elkins WR, London WT, Montali RJ, Goldstein S, Brown C. Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol. 1995 Feb;69(2):955–967. [PMC free article] [PubMed]
  • Hosie MJ, Jarrett O. Serological responses of cats to feline immunodeficiency virus. AIDS. 1990 Mar;4(3):215–220. [PubMed]
  • Ishida T, Tomoda I. Clinical staging of feline immunodeficiency virus infection. Nihon Juigaku Zasshi. 1990 Jun;52(3):645–648. [PubMed]
  • Ishida T, Washizu T, Toriyabe K, Motoyoshi S, Tomoda I, Pedersen NC. Feline immunodeficiency virus infection in cats of Japan. J Am Vet Med Assoc. 1989 Jan 15;194(2):221–225. [PubMed]
  • Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993 Mar;57(1):183–289. [PMC free article] [PubMed]
  • Lutz H, Pedersen NC, Durbin R, Theilen GH. Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27. J Immunol Methods. 1983 Jan 28;56(2):209–220. [PubMed]
  • Michael NL, Mo T, Merzouki A, O'Shaughnessy M, Oster C, Burke DS, Redfield RR, Birx DL, Cassol SA. Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J Virol. 1995 Mar;69(3):1868–1877. [PMC free article] [PubMed]
  • Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, Al BJ, Roos M, Lange JM, Danner SA, Goudsmit J, et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest. 1988 Dec;82(6):1908–1914. [PMC free article] [PubMed]
  • Murphey-Corb M, Martin LN, Davison-Fairburn B, Montelaro RC, Miller M, West M, Ohkawa S, Baskin GB, Zhang JY, Putney SD, et al. A formalin-inactivated whole SIV vaccine confers protection in macaques. Science. 1989 Dec 8;246(4935):1293–1297. [PubMed]
  • O'Neil LL, Burkhard MJ, Diehl LJ, Hoover EA. Vertical transmission of feline immunodeficiency virus. AIDS Res Hum Retroviruses. 1995 Jan;11(1):171–182. [PubMed]
  • Pedersen NC, Ho EW, Brown ML, Yamamoto JK. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science. 1987 Feb 13;235(4790):790–793. [PubMed]
  • Piatak M, Jr, Luk KC, Williams B, Lifson JD. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques. 1993 Jan;14(1):70–81. [PubMed]
  • Piatak M, Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, Lifson JD. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993 Mar 19;259(5102):1749–1754. [PubMed]
  • Piatak M, Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, Lifson JD. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS. 1993 Nov;7 (Suppl 2):S65–S71. [PubMed]
  • Lee TH, Stromberg RR, Henrard D, Busch MP. Effect of platelet-associated virus on assays of HIV-1 in plasma. Science. 1993 Dec 3;262(5139):1585–1586. [PubMed]
  • Saag MS. Evolving understanding of the immunopathogenesis of HIV. AIDS Res Hum Retroviruses. 1994 Aug;10(8):887–892. [PubMed]
  • Saksela K, Stevens C, Rubinstein P, Baltimore D. Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1104–1108. [PubMed]
  • Shelton GH, Linenberger ML, Grant CK, Abkowitz JL. Hematologic manifestations of feline immunodeficiency virus infection. Blood. 1990 Sep 15;76(6):1104–1109. [PubMed]
  • Sodora DL, Shpaer EG, Kitchell BE, Dow SW, Hoover EA, Mullins JI. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol. 1994 Apr;68(4):2230–2238. [PMC free article] [PubMed]
  • Sparger EE, Luciw PA, Elder JH, Yamamoto JK, Lowenstine LJ, Pedersen NC. Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats. AIDS. 1989;3 (Suppl 1):S43–S49. [PubMed]
  • Steinman R, Dombrowski J, O'Connor T, Montelaro RC, Tonelli Q, Lawrence K, Seymour C, Goodness J, Pedersen NC, Andersen PR. Biochemical and immunological characterization of the major structural proteins of feline immunodeficiency virus. J Gen Virol. 1990 Mar;71(Pt 3):701–706. [PubMed]
  • Tompkins MB, Nelson PD, English RV, Novotney C. Early events in the immunopathogenesis of feline retrovirus infections. J Am Vet Med Assoc. 1991 Nov 15;199(10):1311–1315. [PubMed]
  • Tompkins MB, Ogilvie GK, Gast AM, Franklin R, Weigel R, Tompkins WA. Interleukin-2 suppression in cats naturally infected with feline leukemia virus. J Biol Response Mod. 1989 Feb;8(1):86–96. [PubMed]
  • Torten M, Franchini M, Barlough JE, George JW, Mozes E, Lutz H, Pedersen NC. Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol. 1991 May;65(5):2225–2230. [PMC free article] [PubMed]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)